"Ascension Sacred Heart Pensacola, Florida, is a full-service hospital with 24/7 emergency care, a children's hospital and medical center. We deliver advanced surgical care for serious and life-threatening injuries and illnesses. Our care teams listen to quickly understand your health needs and deliver care that's right for you. Ascension Sacred Heart is a destination for specialty care - including cardiology, cancer, neurology, pediatrics, wound care and women’s health. Our OB-GYN maternity care teams at our Birthing Center deliver a personalized birthing experience. We offer a wide range of minimally invasive procedures, diagnostic imaging, lab tests, and cardiopulmonary rehabilitation, all on one campus."

During the past decade, Sacred Heart Hospital conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 41 clinical trials were completed, i.e. on average, 56.2% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 22 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sacred Heart Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "Children's Oncology Group" with 24 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacred Heart Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Children's Oncology Group" with 3 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Sacred Heart Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Coronary Artery Disease" (6 trials), "Acute Lymphoblastic Leukemia" (5 trials) and "Recurrent Neuroblastoma" (5 trials). Many other conditions were trialed in "Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "Sacred Heart Hospital" are "Drug" (83 trials), "Other" (69 trials), "Biological" (42 trials), "Procedure" (31 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (23 trials), "Questionnaire Administration" (20 trials), "Biospecimen Collection" (18 trials) and "Computed Tomography" (16 trials). Other intervention names were less common.

The vast majority of trials in "Sacred Heart Hospital" are 102 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sacred Heart Hospital". undefined are not yet recruiting, 33 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 43 completed trials in Sacred Heart Hospital, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sacred Heart Hospital, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".